Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.
Vous n'êtes pas connecté
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose concerns.
Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.
Kinder Morgan (KMI) generates stable fee-based revenues from its vast network of midstream infrastructure. However, a slowdown in drilling activities...
Golar LNG's (GLNG) shareholder-friendly approach bodes well for the company. However, GLNG is grappling with a surge in vessel operating expenses.
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share gains driven by...
EOG Resources (EOG) is dedicated to sustainability and resilience, with emission reduction pathways and water reuse programs positioning it well in...
Quest Diagnostics (DGX) signs an agreement to acquire Allina Health's select laboratory assets. The deal is aimed at expanding Quest Diagnostics'...
Colgate (CL) benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Roper (ROP) gains from solid momentum in its businesses, acquired assets and shareholder-friendly moves. However, rising operating costs and high...
Healthy demand for premier office spaces and long-term leases from tenants bode well for Boston Properties (BXP). However, elevated interest rates...